Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-02

Clinical Trial Update: Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of single oral doses of lasmiditan when coadministered with single oral doses of sumatriptan in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lasmiditan (Lasmiditan)
  • Sumatriptan (Sumatriptan)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2019-12-02